Showing results (71-80 of 165) with videos related to

Sort By:
Pageof 17
The Lancet. Haematology|May 16, 2022
Addition of navitoclax to ongoing ruxolitinib treatment in patients with myelofibrosis (REFINE): a post-hoc analysis of molecular biomarkers in a phase 2 studyNaveen Pemmaraju, Jacqueline S Garcia, Jalaja Potluri, et al.
Yeast (Chichester, England)|September 19, 2024
Exploring Saccharomycotina Yeast Ecology Through an Ecological Ontology FrameworkMarie-Claire Harrison, Dana A Opulente, John F Wolters, et al.
Blood Advances|August 2, 2023
Matching-adjusted indirect comparison of the pelabresib-ruxolitinib combination vs JAKi monotherapy in myelofibrosisVikas Gupta, John Mascarenhas, Marina Kremyanskaya, et al.
Haematologica|May 28, 2026
Autoimmune cytopenias following alemtuzumab-induced renal transplant: clinical features and treatment outcomesElisa Lucchini, Lucy Kamuriwo, Sarah Gleeson, et al.
British Journal of Haematology|July 8, 2022
Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T-cell phenotypePatrick Harrington, Richard Dillon, Deepti Radia, et al.
BMC Cancer|January 9, 2025
Fedratinib combined with ropeginterferon alfa-2b in patients with myelofibrosis (FEDORA): study protocol for a multicentre, open-label, Bayesian phase II trialGraham McIlroy, Charlotte Gaskell, Aimee Jackson, et al.
Future Oncology (London, England)|June 6, 2025
Indirect treatment comparison of momelotinib vs fedratinib safety in patients with myelofibrosisLucia Masarova, Srdan Verstovsek, Francesca Palandri, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2024
Machine learning enables identification of an alternative yeast galactose utilization pathwayMarie-Claire Harrison, Emily J Ubbelohde, Abigail L LaBella, et al.
Plos Genetics|March 17, 2026
Machine learning identifies novel signatures of antifungal drug resistance in Saccharomycotina yeastsMarie-Claire Harrison, David C Rinker, Abigail L LaBella, et al.
Current Biology : CB|November 5, 2022
Contrasting modes of macro and microsynteny evolution in a eukaryotic subphylumYuanning Li, Hongyue Liu, Jacob L Steenwyk, et al.
Pageof 17